Seeing Is Believing
Reneo Pharmaceuticals's activity chart (see below) currently has 15 price targets and 16 ratings on display.
Analysts average stock forecasts to be materialized ratio is 86.36% with an average time for these price targets to be met of 169.91 days.
Most recent stock forecast was given by from HC WAINWRIGHT on 14-May-2024. First documented stock forecast 04-May-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-May-2024
$30
2 years 3 months 26 days ago
(14-May-2024)
3/4 (75%)
$15.8 (111.27%)
67
$1.8
$-0.02 (-1.10%)
$24
2 years 8 months 25 days ago
(15-Dec-2023)
2/2 (100%)
$-12.4 (-87.32%)
321
Hold Since 15-Dec-2023
$15
2 years 8 months 25 days ago
(15-Dec-2023)
1/1 (100%)
$-19.9 (-57.02%)
630
Buy Since 04-May-2021
$4
$2.18 (119.78%)
2 years 8 months 26 days ago
(14-Dec-2023)
5/5 (100%)
$-9.4 (-70.15%)
222
Buy Since 19-Sep-2022
$30
$28.18 (1548.35%)
$30
3 years 1 days ago
(08-Sep-2023)
3/3 (100%)
$-41.1 (-57.81%)
71
What is RPHM (Reneo Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on RPHM (Reneo Pharmaceuticals)?
Which analyst has the most public recommendations on RPHM (Reneo Pharmaceuticals)?
Which analyst is the currently most bullish on RPHM (Reneo Pharmaceuticals)?
Which analyst is the currently most reserved on RPHM (Reneo Pharmaceuticals)?